Literature DB >> 20083694

Buschke-Ollendorff syndrome: absence of LEMD3 mutation in an affected family.

Michelle Yadegari1, Michael P Whyte, Steven Mumm, Robert G Phelps, Alan Shanske, William G Totty, Steven R Cohen.   

Abstract

BACKGROUND: Buschke-Ollendorff syndrome (BOS), an autosomal dominant disorder, features small, acquired, asymptomatic, symmetrical foci of osteosclerosis detected radiographically in epimetaphyseal bone (osteopoikilosis) (OPK) together with connective tissue nevi or juvenile elastomas. Heterozygous, loss-of-function, germline mutation in the LEMD3 gene (which encodes an inner nuclear membrane protein called LEMD3, or MAN1) has been repeatedly documented in patients with BOS or OPK. OBSERVATIONS: We describe a father and son with multiple yellowish papules and nodules coalescing into cobblestone nevoid plaques consistent with nevus elasticus. Radiographs of the father show multiple, small, bone islands within the hands, wrists, distal femurs, proximal tibias, and left distal fibula consistent with OPK. Although the clinical findings are diagnostic of Buschke-Ollendorf syndrome, analysis of the LEMD3 gene showed no exonic mutations.
CONCLUSION: Absence of LEMD3 mutation in the exons and splice sites of a family with BOS suggests that there is genetic heterogeneity for this disorder.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20083694     DOI: 10.1001/archdermatol.2009.320

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  8 in total

Review 1.  Phenotypic spectrum and management of sternal cleft: literature review and presentation of a new series.

Authors:  Michele Torre; Giovanni Rapuzzi; Marcello Carlucci; Luca Pio; Vincenzo Jasonni
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

2.  Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS.

Authors:  Michael P Whyte; Malachi Griffith; Lee Trani; Steven Mumm; Gary S Gottesman; William H McAlister; Kilannin Krysiak; Robert Lesurf; Zachary L Skidmore; Katie M Campbell; Ilana S Rosman; Susan Bayliss; Vinieth N Bijanki; Angela Nenninger; Brian A Van Tine; Obi L Griffith; Elaine R Mardis
Journal:  Bone       Date:  2017-04-21       Impact factor: 4.398

3.  LEM domain-containing protein 3 antagonizes TGFβ-SMAD2/3 signaling in a stiffness-dependent manner in both the nucleus and cytosol.

Authors:  Dwight M Chambers; Leandro Moretti; Jennifer J Zhang; Spencer W Cooper; Davis M Chambers; Philip J Santangelo; Thomas H Barker
Journal:  J Biol Chem       Date:  2018-08-14       Impact factor: 5.157

4.  Buschke-Ollendorff syndrome presenting as a painful nodule.

Authors:  William C Schaffenburg; Colby Fernelius; Navin S Arora
Journal:  JAAD Case Rep       Date:  2015-03-09

5.  Helen Ollendorff-Curth: A dermatologist's lasting legacy.

Authors:  Anthony K Guzman; William D James
Journal:  Int J Womens Dermatol       Date:  2016-07-18

6.  Helen Ollendorff Curth: A dermatologist's lasting legacy.

Authors:  Anthony K Guzman; William D James
Journal:  Int J Womens Dermatol       Date:  2017-02-16

7.  The Buschke-Ollendorff syndrome: a case report of simultaneous osteo-cutaneous malformations in the hand.

Authors:  Michael Brodbeck; Q Yousif; P A Diener; M Zweier; J Gruenert
Journal:  BMC Res Notes       Date:  2016-06-07

8.  Mutation in LEMD3 (Man1) Associated with Osteopoikilosis and Late-Onset Generalized Morphea: A New Buschke-Ollendorf Syndrome Variant.

Authors:  Benjamin Korman; Jun Wei; Anne Laumann; Polly Ferguson; John Varga
Journal:  Case Rep Dermatol Med       Date:  2016-06-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.